Innodem Neurosciences is Other Healthcare Technology Systems in Canada that focus on track disease business. Founded in 2016. They cover business area such as developer, neurodegenerative disease, healthcare professional, abnormality, assess and track disease progression, treatment, healthy control, various neurological disorder, doctor, quantitative measure, saccade, pursuit, velocity, latency, amplitude.
Other Healthcare Technology Systems
2016
( 8 years old in 2024 )
Track Disease
-
5605 Avenue de Gaspé
Suite 204
Montreal, Quebec H2T 2A4
Canada
Private
developerneurodegenerative diseasehealthcare professionalabnormalityassess and track disease progressiontreatmenthealthy controlvarious neurological disorderdoctorquantitative measuresaccadepursuitvelocitylatencyamplitude
* We use standard office opening hours in near Innodem Neurosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Innodem Neurosciences is Other Healthcare Technology Systems business from Canada that founded in 2016 (8 years old in 2024), Innodem Neurosciences business is focusing on Track Disease.
Innodem Neurosciences headquarter office and corporate office address is located in 5605 Avenue de Gaspé Suite 204 Montreal, Quebec H2T 2A4 Canada.
Innodem Neurosciences was founded in Canada.
In 2024, Innodem Neurosciences is currently focus on track disease sector.
Above is snippet of Google Trends for "track disease" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Innodem Neurosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
